title: Prognostic evaluation of cutaneous malignant melanoma: a clinicopathologic and immunohistochemical study.
abstract: OBJECTIVE
  Depth of invasion and stage of the disease are established prognostic indicators in cutaneous malignant melanoma. The role of other parameters is still an open problem.
  
  
  METHODS
  In 93 consecutive patients with cutaneous malignant melanoma, the level of invasion, tumor thickness, ulceration, vascular invasion, lymphoplasmocytic infiltrates, and mitotic index were evaluated by histology. Expression of Ki-67 and PCNA proliferative antigens together with vimentin, S100, and HMB 45 proteins were assessed by immunohistochemistry.
  
  
  CONCLUSIONS
  Disease-free and overall survival were correlated with tumor stage, tumor thickness, level of invasion, macroscopic pattern, ulceration, vascular invasion, expression of HMB 45, PCNA, and Ki-67/MIB1. Stage, HMB 45, and PCNA were independent prognostic factors for disease-free survival, whereas tumor stage, tumor thickness, and expression of both proliferative antigens influenced overall survival independently. The variables studied demonstrated reciprocal correlation; therefore, analysis of many prognostic parameters in malignant melanoma could be recommended.
authors: Department of Pathology, Oncology Center, Cracow, Poland. z5rys@cyf-kr.edu.pl
authors: A
authors: A
authors: Niezabitowski
authors: K
authors: K
authors: Czajecki
authors: J
authors: J
authors: Ryś
authors: A
authors: A
authors: Kruczak
authors: A
authors: A
authors: Gruchała
authors: A
authors: A
authors: Wasilewska
authors: B
authors: B
authors: Lackowska
authors: A
authors: A
authors: Sokołowski
authors: W
authors: W
authors: Szklarski
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D000951:Antigens, Neoplasm; D002455:Cell Division; D017024:Chemotherapy, Adjuvant; D062109:Dermatologic Surgical Procedures; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D019394:Ki-67 Antigen / Q000032:analysis; D008197:Lymph Node Excision; D008297:Male; D008545:Melanoma / Q000378:metabolism / Q000473:pathology* / Q000628:therapy; D058950:Melanoma-Specific Antigens; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009363:Neoplasm Proteins / Q000032:analysis; D011379:Prognosis; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis; D016016:Proportional Hazards Models; D012878:Skin Neoplasms / Q000378:metabolism / Q000473:pathology* / Q000628:therapy; D014746:Vimentin / Q000032:analysis
chemical_list: D000951:Antigens, Neoplasm; D019394:Ki-67 Antigen; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins; D018809:Proliferating Cell Nuclear Antigen; D014746:Vimentin